| Literature DB >> 31090539 |
Esther Zumaquero1, Sara L Stone1, Christopher D Scharer2, Scott A Jenks3, Anoma Nellore4, Betty Mousseau1, Antonio Rosal-Vela1, Davide Botta1, John E Bradley5, Wojciech Wojciechowski6, Travis Ptacek1,7, Maria I Danila5, Jeffrey C Edberg5, S Louis Bridges5, Robert P Kimberly5, W Winn Chatham5, Trenton R Schoeb8, Alexander F Rosenberg1,9, Jeremy M Boss2, Ignacio Sanz3, Frances E Lund1.
Abstract
Although B cells expressing the IFNγR or the IFNγ-inducible transcription factor T-bet promote autoimmunity in Systemic Lupus Erythematosus (SLE)-prone mouse models, the role for IFNγ signaling in human antibody responses is unknown. We show that elevated levels of IFNγ in SLE patients correlate with expansion of the T-bet expressing IgDnegCD27negCD11c+CXCR5neg (DN2) pre-antibody secreting cell (pre-ASC) subset. We demonstrate that naïve B cells form T-bethi pre-ASCs following stimulation with either Th1 cells or with IFNγ, IL-2, anti-Ig and TLR7/8 ligand and that IL-21 dependent ASC formation is significantly enhanced by IFNγ or IFNγ-producing T cells. IFNγ promotes ASC development by synergizing with IL-2 and TLR7/8 ligands to induce genome-wide epigenetic reprogramming of B cells, which results in increased chromatin accessibility surrounding IRF4 and BLIMP1 binding motifs and epigenetic remodeling of IL21R and PRDM1 loci. Finally, we show that IFNγ signals poise B cells to differentiate by increasing their responsiveness to IL-21.Entities:
Keywords: B lymphocytes; T-bet; antibody secreting cells; human; immunology; inflammation; interferons; mouse; systemic lupus erythematosus
Mesh:
Substances:
Year: 2019 PMID: 31090539 PMCID: PMC6544433 DOI: 10.7554/eLife.41641
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140